Brexit Health Alliance respond to Brexit report

pharmafield logo - pharma news

Responding to the Health and Social Care Committee’s Report “Brexit: medicines, medical devices and substances of human origin”, Niall Dickson, co-chair of the Brexit Health Alliance, said:

“We support the sensible and practical recommendations of this report and believe they highlight the important issues that will need to be addressed to preserve public health and patient safety in the UK and the EU after Brexit.

“We need patients and public health to be put first in the next phase of the negotiations. This means that both sides need urgently to address the future cooperation model, and what this will mean for health. We need this clarity as soon as possible during the negotiation process to ensure there is sufficient time to prepare for whatever comes after the transition period, which is still unknown.”